Ricardo Costa

3.2k total citations · 1 hit paper
82 papers, 2.2k citations indexed

About

Ricardo Costa is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Ricardo Costa has authored 82 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Oncology, 36 papers in Pulmonary and Respiratory Medicine and 18 papers in Cancer Research. Recurrent topics in Ricardo Costa's work include HER2/EGFR in Cancer Research (19 papers), Cancer Immunotherapy and Biomarkers (17 papers) and Advanced Breast Cancer Therapies (16 papers). Ricardo Costa is often cited by papers focused on HER2/EGFR in Cancer Research (19 papers), Cancer Immunotherapy and Biomarkers (17 papers) and Advanced Breast Cancer Therapies (16 papers). Ricardo Costa collaborates with scholars based in United States, Brazil and Portugal. Ricardo Costa's co-authors include William J. Gradishar, Hyo S. Han, Benedito A. Carneiro, Francis J. Giles, Brian J. Czerniecki, Young Kwang Chae, Massimo Cristofanilli, Aparna Kalyan, Alfred Rademaker and Marcelo Cruz and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ricardo Costa

74 papers receiving 2.1k citations

Hit Papers

Targeting the PI3K/AKT/mTOR pathway in triple-negative br... 2018 2026 2020 2023 2018 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review
    2018 337 citations Ricardo Costa, Hyo S. Han et al. Breast Cancer Research and Treatment profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ricardo Costa United States 22 1.1k 848 601 540 268 82 2.2k
Yutaka Hatanaka Japan 27 1.2k 1.0× 712 0.8× 653 1.1× 533 1.0× 303 1.1× 143 2.2k
Akihiko Shimomura Japan 22 1.1k 1.0× 751 0.9× 536 0.9× 537 1.0× 147 0.5× 132 2.0k
Raffael Kurek Germany 18 1.0k 0.9× 963 1.1× 721 1.2× 563 1.0× 267 1.0× 39 2.2k
Stephen Leong United States 23 1.1k 1.0× 842 1.0× 471 0.8× 606 1.1× 178 0.7× 73 2.3k
Jermaine Coward Australia 23 1.2k 1.1× 704 0.8× 380 0.6× 354 0.7× 404 1.5× 87 2.3k
Ana C. Garrido-Castro United States 12 1.4k 1.2× 649 0.8× 502 0.8× 474 0.9× 287 1.1× 54 2.2k
G. Deplanque France 23 1.3k 1.1× 633 0.7× 812 1.4× 542 1.0× 199 0.7× 77 2.3k
Yong Wha Moon South Korea 22 918 0.8× 658 0.8× 685 1.1× 335 0.6× 301 1.1× 69 1.8k
Deepa S. Subramaniam United States 25 922 0.8× 810 1.0× 793 1.3× 378 0.7× 205 0.8× 81 2.2k
Joe Stephenson United States 25 1.1k 1.0× 894 1.1× 488 0.8× 360 0.7× 429 1.6× 65 2.0k

Countries citing papers authored by Ricardo Costa

Since Specialization
Citations

This map shows the geographic impact of Ricardo Costa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ricardo Costa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ricardo Costa more than expected).

Fields of papers citing papers by Ricardo Costa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ricardo Costa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ricardo Costa. The network helps show where Ricardo Costa may publish in the future.

Co-authorship network of co-authors of Ricardo Costa

This figure shows the co-authorship network connecting the top 25 collaborators of Ricardo Costa. A scholar is included among the top collaborators of Ricardo Costa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ricardo Costa. Ricardo Costa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Hyo S., Amy L. Aldrich, Saurabh Garg, et al.. (2024). Alteration of the Tumor Microenvironment With Intratumoral Dendritic Cells Before Chemotherapy in ERBB2 Breast Cancer. JAMA Oncology. 11(2). 119–119. 1 indexed citations
2.
Soliman, Hatem, Hyo S. Han, Blaise Mooney, et al.. (2023). Oncolytic T-VEC virotherapy plus neoadjuvant chemotherapy in nonmetastatic triple-negative breast cancer: a phase 2 trial. Nature Medicine. 29(2). 450–457. 50 indexed citations
3.
4.
Cesca, Marcelle Goldner, et al.. (2023). 481P Second generation oral selective estrogen receptor degraders (SERDs) in breast cancer: A systematic review and meta-analysis of clinical trials. Annals of Oncology. 34. S383–S383. 1 indexed citations
5.
6.
Barakat, Elie, Anupam Rishi, Jessica M. Frakes, et al.. (2021). Transarterial Yttrium-90 Glass Microsphere Radioembolization of Chemotherapy-Refractory Breast Cancer Liver Metastases: Results of a Single Institution Retrospective Study. Advances in Radiation Oncology. 7(1). 100838–100838. 7 indexed citations
7.
Sun, James, Junjie Ma, Weihong Sun, et al.. (2021). Real‐world benefit of combination palbociclib and endocrine therapy for metastatic breast cancer and correlation with neutropenia. Cancer Medicine. 10(21). 7665–7672. 13 indexed citations
8.
Artzy‐Randrup, Yael, Tamir Epstein, Joel S. Brown, et al.. (2021). Novel evolutionary dynamics of small populations in breast cancer adjuvant and neoadjuvant therapy. npj Breast Cancer. 7(1). 26–26. 8 indexed citations
9.
Costa, Ricardo, Saif Zaman, Susan C. Sharpe, et al.. (2019). A brief report of toxicity end points of HER2 vaccines for the treatment of patients with HER2<sup>+</sup> breast cancer. Drug Design Development and Therapy. Volume 13. 309–316. 14 indexed citations
10.
Mills, Matthew N., G.Q. Yang, Daniel Oliver, et al.. (2018). Histologic heterogeneity of triple negative breast cancer: A National Cancer Centre Database analysis. European Journal of Cancer. 98. 48–58. 62 indexed citations
11.
Rossi, Giovanna, Zhaomei Mu, Alfred Rademaker, et al.. (2017). Cell-Free DNA and Circulating Tumor Cells: Comprehensive Liquid Biopsy Analysis in Advanced Breast Cancer. Clinical Cancer Research. 24(3). 560–568. 106 indexed citations
12.
Costa, Ricardo, Alfred Rademaker, Benedito A. Carneiro, et al.. (2017). Systematic analysis of early phase clinical studies for patients with breast cancer: Inclusion of patients with brain metastasis. Cancer Treatment Reviews. 55. 10–15. 17 indexed citations
13.
Costa, Ricardo, Cesar A. Santa‐Maria, Denise Scholtens, et al.. (2017). A pilot study of cabergoline for the treatment of metastatic breast cancer. Breast Cancer Research and Treatment. 165(3). 585–592. 16 indexed citations
14.
Pai, Sachin Gopalkrishna, Benedito A. Carneiro, Young Kwang Chae, et al.. (2017). Correlation of tumor mutational burden and treatment outcomes in patients with colorectal cancer. Journal of Gastrointestinal Oncology. 8(5). 858–866. 36 indexed citations
15.
Chae, Young Kwang, Sachin Gopalkrishna Pai, Peng Sun, et al.. (2016). Fibroblast Growth Factor Receptor (FGFR) as a Therapeutic Target in Lung and Head and Neck Cancer. 12(3). 6 indexed citations
16.
Agulnik, Mark, Ricardo Costa, Mohammed Milhem, et al.. (2016). A phase II study of tivozanib in patients with metastatic and nonresectable soft-tissue sarcomas. Annals of Oncology. 28(1). 121–127. 23 indexed citations
17.
Costa, Ricardo, et al.. (2014). Follicular Lymphoma Presenting with Leptomeningeal Disease. SHILAP Revista de lepidopterología. 2014. 1–3. 4 indexed citations
18.
Bento, Celeste, Ana Oliveira, Joana B. Neves, et al.. (2013). Hb Plasencia [ α 125(H8)Leu→Arg ( α 2)] is a Frequent Cause of α + -Thalassemia in the Portuguese Population. Hemoglobin. 37(2). 183–187. 1 indexed citations
19.
Costa, J. Ribamar, Alexandre Abizaid, Ricardo Costa, et al.. (2011). PRELIMINARY RESULTS OF THE MULTICENTRIC, DOUBLE-BLINDED, RANDOMIZED, VESTASYNC II TRIAL. Journal of the American College of Cardiology. 57(14). E1831–E1831. 1 indexed citations
20.
Stoodley, Paul, Ricardo Costa, Duncan Richards, & Liza Thomas. (2007). Acute myocardial infarction complicated by LV free wall rupture: The benefits of echocardiography. European Journal of Echocardiography. 9(1). 188–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yutaka Hatanaka Breakdown of academic impact, for papers by Akihiko Shimomura Breakdown of academic impact, for papers by Raffael Kurek Breakdown of academic impact, for papers by Stephen Leong Breakdown of academic impact, for papers by Jermaine Coward Breakdown of academic impact, for papers by Ana C. Garrido-Castro Breakdown of academic impact, for papers by G. Deplanque Breakdown of academic impact, for papers by Yong Wha Moon Breakdown of academic impact, for papers by Deepa S. Subramaniam Breakdown of academic impact, for papers by Joe Stephenson
Rankless by CCL
2026